Standard BioTools
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-17.72-5.82-2.77-3.20-5.79-3.58-8.15-5.01-0.48-2.34-2.44-5.79
Price/Sales ratio
8.042.702.021.903.021.983.122.270.931.642.292.29
Price/Book Value ratio
6.222.703.966.274.731.513.103.14-1.121.0712.924.73
Price/Cash Flow ratio
-41.40-8.94-5.40-8.06-13.56-6.60-28.03-6.74-1.02-4.04-6.11-13.56
Price/Free Cash Flow ratio
-31.19-6.84-4.78-7.55-13.36-6.15-15.36-5.18-0.98-3.79-5.29-13.36
Price/Earnings Growth ratio
-0.082.76-0.060.100.300.100.34-0.92-0.000.030.960.30
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
63.20%59.35%55.94%50.99%54.57%54.82%60.31%53.12%37.82%47.44%50.34%54.82%
Operating Profit Margin
-44.51%-43.72%-70.07%-57.25%-42.63%-44.21%-36.94%-51.66%-118.63%-72.03%-60.85%-44.21%
Pretax Profit Margin
-49.55%-47.76%-76.76%-62.58%-54.37%-56.89%-39.16%-48.75%-196.96%-69.78%-96.57%-56.89%
Net Profit Margin
-45.36%-46.47%-72.75%-59.38%-52.24%-55.26%-38.38%-45.36%-194.08%-70.20%-93.89%-55.26%
Effective Tax Rate
8.44%2.69%5.22%5.11%3.91%2.87%1.99%6.94%1.46%-0.60%2.77%2.87%
Return on Assets
-12.96%-14.36%-24.79%-21.06%-19.43%-24.46%-16.32%-21.52%-48.70%-23.10%-42.91%-24.46%
Return On Equity
-35.12%-46.40%-142.74%-195.68%-81.83%-42.17%-38.13%-62.62%233.34%-45.74%-143.41%-42.17%
Return on Capital Employed
-13.70%-14.70%-26.43%-22.98%-18.10%-22.34%-18.86%-29.89%-33.50%-35.83%-33.65%-22.34%
Liquidity Ratios
Current Ratio
5.304.793.272.833.382.922.16N/AN/AN/A1.552.92
Quick Ratio
4.764.192.592.383.032.501.801.034.311.250.962.50
Cash ratio
1.140.961.181.732.530.651.260.571.870.470.630.65
Days of Sales Outstanding
70.1581.0051.0553.8853.8059.0967.1751.2064.3967.4845.2859.09
Days of Inventory outstanding
136.21140.30159.56110.2492.4895.68131.09124.18128.70134.09137.4692.48
Operating Cycle
206.37221.30210.62164.12146.29154.77198.26175.39193.09201.57148.62146.29
Days of Payables Outstanding
50.4147.7031.4730.7628.6435.5061.3963.2247.4360.3174.0228.64
Cash Conversion Cycle
155.95173.60179.15133.35117.64119.26136.87112.17145.66141.255.16119.26
Debt Ratios
Debt Ratio
0.470.520.630.670.560.210.170.250.170.200.910.56
Debt Equity Ratio
1.291.693.666.312.380.360.410.75-0.840.4111.292.38
Long-term Debt to Capitalization
0.560.620.780.860.700.250.280.40-3.360.020.860.70
Total Debt to Capitalization
0.560.620.780.860.700.260.290.42-5.310.290.860.70
Interest Coverage Ratio
-7.69-9.32-12.57-10.02-3.46-12.11-14.28N/AN/AN/A-19.07-12.11
Cash Flow to Debt Ratio
-0.11-0.17-0.20-0.12-0.14-0.63-0.26-0.62-1.30-0.63-0.33-0.33
Company Equity Multiplier
2.703.225.759.284.211.722.332.90-4.791.9712.294.21
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.19-0.30-0.37-0.23-0.22-0.30-0.11-0.33-0.91-0.40-0.37-0.30
Free Cash Flow / Operating Cash Flow Ratio
1.321.301.121.061.011.071.821.301.041.061.151.01
Cash Flow Coverage Ratio
-0.11-0.17-0.20-0.12-0.14-0.63-0.26-0.62-1.30-0.63-0.33-0.33
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-19.20-5.18-6.44-15.50-0.67-14.56-19.20
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A